A Clinical trial to study of Jyotishmatyadi churna and matra basti of Satpushpa tail in patients of Artavakshaya w.s.r. Oligo-Hypomenorhhea.

A Comparative clinical study to evaluate the effect of Jyotishmatyadi churna alongwith Satpushpa taila Matra basti in the management of Artavakshaya wsr to Oligo-Hypomenorhhea

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046184

Enrollment

Registered

2022-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1- Patients between the age group of 18-40 years. 2- patients fulfilling cardinal symptoms of Artavakshaya. 3- patients willing to participate in the study with proper written consent.

Exclusion criteria

Exclusion criteria: 1- patient having systemic diseases(HTN,TB,DM) 2- Thyroid disorder 3- Pregnant & lactating women 4- patient onOCPs,IUCD 5- Congenital anomalies of uterus or ovaries 6- Patient with any pelvic pathology or malignancy 7- PCOD 8- Hb% less than 10 gm

Design outcomes

Primary

Measure	Time frame
1- To assess the efficacy of Jyotishmatyadi churna along with satpushpa taila Matra Basti inthe management of Artavakshaya. 2- To assess the efficacy of trial therapy on subjective parameters like interval between two cycle,duration of bleeding,amount of blood loss and pain during menstruation- assess with the help of VAS scale.Timepoint: 3 consecutive cycle (2 cycle with trial drug and one cycle drug free follow up.	—

Measure

Time frame

1- To assess the efficacy of Jyotishmatyadi churna along with satpushpa taila Matra Basti inthe management of Artavakshaya. 2- To assess the efficacy of trial therapy on subjective parameters like interval between two cycle,duration of bleeding,amount of blood loss and pain during menstruation- assess with the help of VAS scale.Timepoint: 3 consecutive cycle (2 cycle with trial drug and one cycle drug free follow up.

—

Secondary

Measure	Time frame
To assess the efficacy of trial therapy on subjective parameters like interval between two cycles,duration of bleeding,amount of blood loss and pain during Menstruation- assess with the help of VAS scale.Timepoint: 3 consecutive cycles (2 cycles with trial drug and one cycle drug free follow up ).	—

Countries

India

Contacts

Public ContactDr Gyan jyoti Chaudhary

State Ayurvedic College and Hospital, Lucknow

shashibedar@yahoo.com7068364242

Outcome results